Related Articles
EXPRESSION OF PS2 AND CATHEPSIN-D IN BREAST-CANCER
Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients
Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study
miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status
Cyclooxygenase‑2 expression in non‑metastatic triple‑negative breast cancer patients